| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018304800 |
| P356 | DOI | 10.1038/KI.2013.56 |
| P698 | PubMed publication ID | 23447067 |
| P5875 | ResearchGate publication ID | 235750497 |
| P50 | author | Friedrich Luft | Q20753057 |
| P2093 | author name string | Jens Jordan | |
| Johannes F Mann | |||
| P2860 | cites work | Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial | Q34150890 |
| Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months | Q34170734 | ||
| Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study | Q34180424 | ||
| Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety | Q34204205 | ||
| Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial | Q34254971 | ||
| ESH position paper: renal denervation - an interventional therapy of resistant hypertension | Q34265325 | ||
| Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study | Q34605979 | ||
| Chronic lowering of blood pressure by carotid baroreflex activation: mechanisms and potential for hypertension therapy | Q34904265 | ||
| Renal denervation: ultima ratio or standard in treatment-resistant hypertension | Q36713381 | ||
| Translational medicine: the antihypertensive effect of renal denervation | Q37643129 | ||
| Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system | Q37829578 | ||
| Role of the Baroreceptor Reflex in Daily Control of Arterial Blood Pressure and Other Variables in Dogs | Q39325078 | ||
| Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial | Q39721026 | ||
| Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. | Q43184350 | ||
| Renal sympathetic-nerve ablation for uncontrolled hypertension | Q43285253 | ||
| Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study | Q43473084 | ||
| Unloading arterial baroreceptors causes neurogenic hypertension | Q43917412 | ||
| Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea | Q44326454 | ||
| Prolonged activation of the baroreflex produces sustained hypotension. | Q44715083 | ||
| Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. | Q45998485 | ||
| Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension. | Q46745892 | ||
| Acute device-based blood pressure reduction: electrical activation of the carotid baroreflex in patients undergoing elective carotid surgery | Q48600112 | ||
| Management of uncontrollable hypertension with a carotid sinus stimulation device. | Q50904991 | ||
| An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension. | Q51083409 | ||
| Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. | Q53933378 | ||
| The effect of carotid sinus nerve stimulation on cardiovascular dynamics in man | Q68432158 | ||
| The principle of electrical carotid sinus nerve stimulation: A nerve pacemaker system for angina pectoris and hypertension therapy | Q70965058 | ||
| Electrical Stimulation of the Carotid Sinus Nerve | Q72350703 | ||
| NEUROGENIC HYPERTENSION IN THE RAT | Q77139383 | ||
| Prolonged activation of the baroreflex abolishes obesity-induced hypertension | Q80167384 | ||
| TOTAL THORACIC AND PARTIAL TO TOTAL LUMBAR SYMPATHECTOMY AND CELIAC GANGLIONECTOMY IN THE TREATMENT OF HYPERTENSION | Q81259036 | ||
| [Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment] | Q82318326 | ||
| Improved cardiac structure and function with chronic treatment using an implantable device in resistant hypertension: results from European and United States trials of the Rheos system | Q83927039 | ||
| Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension | Q84264441 | ||
| Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension | Q84447416 | ||
| Secondary rise in blood pressure after renal denervation | Q84866795 | ||
| Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series | Q87418200 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 250-255 | |
| P577 | publication date | 2013-02-27 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Research needs in the area of device-related treatments for hypertension | |
| P478 | volume | 84 |
Search more.